Licensing Opportunity: Virus-Like Particle Technology for Universal Flu Vaccine
Reformulating influenza vaccines annually against dominant circulating strains leads to variable protective efficacy and is unlikely to protect against novel ...
Reformulating influenza vaccines annually against dominant circulating strains leads to variable protective efficacy and is unlikely to protect against novel ...
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking statements of capability or interest from parties interested in ...
The U.S. Department of Energy’s (DOE) Office of Technology Transitions (OTT) has announced a COVID-19 Technical Assistance Program (CTAP) that provides funding ...
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that its nasopharyngeal swab and genomic toehold switch ...